SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-124870
Filing Date
2021-10-12
Accepted
2021-10-12 06:02:19
Documents
16
Period of Report
2021-10-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2129667d2_8k.htm   iXBRL 8-K 64632
2 EXHIBIT 2.1 tm2129667d2_ex2-1.htm EX-2.1 843484
3 EXHIBIT 10.1 tm2129667d2_ex10-1.htm EX-10.1 97241
4 EXHIBIT 99.1 tm2129667d2_ex99-1.htm EX-99.1 73468
8 GRAPHIC tm2129667d2_ex99-1img001.jpg GRAPHIC 3860
  Complete submission text file 0001104659-21-124870.txt   1492055

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA flxn-20211011.xsd EX-101.SCH 3222
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE flxn-20211011_lab.xml EX-101.LAB 34594
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE flxn-20211011_pre.xml EX-101.PRE 22735
9 EXTRACTED XBRL INSTANCE DOCUMENT tm2129667d2_8k_htm.xml XML 3613
Mailing Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803
Business Address 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 (781) 305-7777
Flexion Therapeutics Inc (Filer) CIK: 0001419600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36287 | Film No.: 211316566
SIC: 2834 Pharmaceutical Preparations